Benjamin Graham · Defensive deep-value investing
Is ADMA Biologics, Inc. (ADMA) a Benjamin Graham Stock?
Meets 5/7 Graham criteria, partially qualifies.
55/100
Does not fit
5/7 criteria passed
Benjamin Graham's Criteria, Applied to ADMA
P/E ≤ 15
key12.0x
P/B ≤ 1.5
key5.1x
Current ratio ≥ 2
7.0x
Debt / Equity ≤ 1
0.5x
How ADMA Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.56B
P/E (TTM)
17.4x
ROIC (TTM)
27.81%
Gross margin
57.39%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is ADMA's Benjamin Graham fit score?
ADMA scores 55/100 on our Benjamin Graham fit engine. Meets 5/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own ADMA?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends ADMA.
How often is this score updated?
ADMA's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends ADMA.
